The Aurora kinases: role in cell transformation and tumorigenesis
- PMID: 12884918
- DOI: 10.1023/a:1023789416385
The Aurora kinases: role in cell transformation and tumorigenesis
Abstract
Aurora kinases representing a novel family of serine/threonine kinases have been identified as key regulators of the mitotic cell division process. The three members of this kinase family, identified so far, referred to as Aurora-A, Aurora-B and Aurora-C kinases, are close homologues of the prototypic yeast Ipll and Drosophila aurora kinases, which are known to be involved in the regulation of centrosome function, bipolar spindle assembly and chromosome segregation processes. All three members of the mammalian kinase family have a catalytic domain that is highly conserved with a short C-terminal domain and an N-terminal domain of varying sizes. Following their discovery about five years ago, extensive research has focused on understanding the biological roles of these kinases and elucidation of their pathways, which regulate cell proliferation and maintenance of normal cellular phenotypes. Significant interest in the subject was generated since all three Aurora kinases family members were reported to be overexpressed in many human cancers, and elevated expression has been correlated with chromosomal instability and clinically aggressive disease in some instances. Ectopic overexpression of one member of the family, Aurora-A, was shown to induce oncogenic transformation in cells. Unlike most other putative oncogenes identified, so far, members of this kinase family are expressed and active at the highest level during G2-M phase of the cell cycle. Aurora kinases are localized at the centrosomes of interphase cells, at the poles of the bipolar spindle and in the midbody of the mitotic apparatus. Substrates identified for the Aurora-A and Aurora-B kinases, include a kinesin-like motor protein, spindle apparatus proteins, histone H3 protein, kinetochore protein and the tumor suppressor protein p53. Identification of Aurora kinases as RasGAP Src homology 3 domain binding protein, also implicates these kinases as potential effectors in the Ras pathway relevant to oncogenesis. Abnormal elevated expression of Aurora kinases detected in human cancer cells could help explain the underlying biological mechanisms responsible for the development of many cellular phenotypes associated with malignant cells. Identification of these mechanisms offers the possibility of designing novel targeted therapies for cancer in the future.
Similar articles
-
Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.Cell Motil Cytoskeleton. 2003 Jun;55(2):134-46. doi: 10.1002/cm.10120. Cell Motil Cytoskeleton. 2003. PMID: 12740874
-
Aurora-A - a guardian of poles.Nat Rev Cancer. 2005 Jan;5(1):42-50. doi: 10.1038/nrc1526. Nat Rev Cancer. 2005. PMID: 15630414 Review.
-
The S. pombe aurora-related kinase Ark1 associates with mitotic structures in a stage dependent manner and is required for chromosome segregation.J Cell Sci. 2001 Dec;114(Pt 24):4371-84. doi: 10.1242/jcs.114.24.4371. J Cell Sci. 2001. PMID: 11792803
-
Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.Pharmacol Ther. 2006 Sep;111(3):974-84. doi: 10.1016/j.pharmthera.2006.02.006. Epub 2006 Apr 17. Pharmacol Ther. 2006. PMID: 16603252 Review.
-
[The function of Aurora A and its role in the development of liver cancer].Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):477-480. doi: 10.3760/cma.j.issn.1007-3418.2017.06.019. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28763871 Chinese.
Cited by
-
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.Cancer Chemother Pharmacol. 2021 Aug;88(2):335-341. doi: 10.1007/s00280-021-04293-3. Epub 2021 May 15. Cancer Chemother Pharmacol. 2021. PMID: 33993383 Free PMC article. Clinical Trial.
-
Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.Invest New Drugs. 2013 Feb;31(1):39-45. doi: 10.1007/s10637-012-9831-9. Epub 2012 Jun 6. Invest New Drugs. 2013. PMID: 22669335 Free PMC article.
-
Regulation of AURKC expression by CpG island methylation in human cancer cells.Tumour Biol. 2015 Sep;36(10):8147-58. doi: 10.1007/s13277-015-3553-5. Epub 2015 May 20. Tumour Biol. 2015. PMID: 25990457
-
Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property.Mol Cell Biol. 2005 Jun;25(12):4977-92. doi: 10.1128/MCB.25.12.4977-4992.2005. Mol Cell Biol. 2005. PMID: 15923616 Free PMC article.
-
Localization of aurora A and aurora B kinases during interphase: role of the N-terminal domain.Cell Cycle. 2008 Oct;7(19):3012-20. doi: 10.4161/cc.7.19.6718. Epub 2008 Oct 26. Cell Cycle. 2008. PMID: 18802402 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous